Literature DB >> 12137674

Interventionist versus expectant care for severe pre-eclampsia before term.

D Churchill1, L Duley.   

Abstract

BACKGROUND: Severe pre-eclampsia can cause significant mortality and morbidity for both mother and child, particularly when it occurs well before term. The only known cure for this disease is delivery. Some obstetricians advocate early delivery to prevent the development of serious maternal complications, such as eclampsia (fits) and kidney failure. Others prefer a more expectant approach in an attempt to delay delivery and, hopefully, reduce the mortality and morbidity for the child associated with being born too early.
OBJECTIVES: The objective of the review was to compare the effects of a policy of interventionist care and early delivery with a policy of expectant care and delayed delivery for women with early onset severe pre-eclampsia. SEARCH STRATEGY: We search the register of trials maintained by the Cochrane Pregnancy and Childbirth Group (April 2002) and the Cochrane Controlled Trials Register (The Cochrane Library, Issue 2, 2002). SELECTION CRITERIA: Randomised trials comparing the two intervention strategies for women with early onset severe pre-eclampsia. DATA COLLECTION AND ANALYSIS: Trial quality was assessed using the criteria set out in the Cochrane Reviewers' Handbook. Data were extracted and checked independently by both reviewers. MAIN
RESULTS: Two trials (133 women) are included in this review. There are insufficient data for reliable conclusions about the comparative effects on outcome for the mother. For the baby, there is insufficient evidence for reliable conclusions about the effects on stillbirth or death after delivery (relative risk (RR) 1.50, 95% confidence interval (CI) 0.42 to 5.41). Babies whose mothers had been allocated to the interventionist group had more hyaline membrane disease (RR 2.3, 95% CI 1.39 to 3.81), more necrotising enterocolitis (RR 5.5, 95% CI 1.04 to 29.56) and were more likely to need admission to neonatal intensive care (RR 1.32, 95% CI 1.13 to 1.55) than those allocated an expectant policy. Nevertheless, babies allocated to the interventionist policy were less likely to be small for gestational age (RR 0.36, 95% CI 0.14 to 0.90). There were no statistically significant differences between the two strategies for any other outcomes. REVIEWER'S
CONCLUSIONS: There are insufficient data for any reliable recommendation about which policy of care should be used for women with severe early onset pre-eclampsia. Further large trials are needed.

Entities:  

Mesh:

Year:  2002        PMID: 12137674     DOI: 10.1002/14651858.CD003106

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  16 in total

Review 1.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 2.  Magnesium sulphate versus lytic cocktail for eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 3.  Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; David J Henderson-Smart; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

4.  Does aggressive and expectant management of severe preeclampsia affect the neurologic development of the infant?

Authors:  Arif Aktuğ Ertekin; Bilge Kapudere; Meryem Kurek Eken; Gülşah İlhan; Şükriye Dırman; Mehmet Akif Sargın; Engin Deniz; Güner Karatekin; Ebru Çöğendez; Murat Api
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 5.  The management of hypertension in pregnancy.

Authors:  Andrea G Kattah; Vesna D Garovic
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

Review 6.  Drugs for treatment of very high blood pressure during pregnancy.

Authors:  Lelia Duley; Shireen Meher; Leanne Jones
Journal:  Cochrane Database Syst Rev       Date:  2013-07-31

7.  Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.

Authors:  John Allotey; Kym Ie Snell; Melanie Smuk; Richard Hooper; Claire L Chan; Asif Ahmed; Lucy C Chappell; Peter von Dadelszen; Julie Dodds; Marcus Green; Louise Kenny; Asma Khalil; Khalid S Khan; Ben W Mol; Jenny Myers; Lucilla Poston; Basky Thilaganathan; Anne C Staff; Gordon Cs Smith; Wessel Ganzevoort; Hannele Laivuori; Anthony O Odibo; Javier A Ramírez; John Kingdom; George Daskalakis; Diane Farrar; Ahmet A Baschat; Paul T Seed; Federico Prefumo; Fabricio da Silva Costa; Henk Groen; Francois Audibert; Jacques Masse; Ragnhild B Skråstad; Kjell Å Salvesen; Camilla Haavaldsen; Chie Nagata; Alice R Rumbold; Seppo Heinonen; Lisa M Askie; Luc Jm Smits; Christina A Vinter; Per M Magnus; Kajantie Eero; Pia M Villa; Anne K Jenum; Louise B Andersen; Jane E Norman; Akihide Ohkuchi; Anne Eskild; Sohinee Bhattacharya; Fionnuala M McAuliffe; Alberto Galindo; Ignacio Herraiz; Lionel Carbillon; Kerstin Klipstein-Grobusch; SeonAe Yeo; Helena J Teede; Joyce L Browne; Karel Gm Moons; Richard D Riley; Shakila Thangaratinam
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

8.  Evidence for perinatal and child health care guidelines in crisis settings: can Cochrane help?

Authors:  Tari J Turner; Hayley Barnes; Jane Reid; Marie Garrubba
Journal:  BMC Public Health       Date:  2010-03-29       Impact factor: 3.295

Review 9.  Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy.

Authors:  Carine Ronsmans; Oona Campbell
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

Review 10.  Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia.

Authors:  Gordon C S Smith
Journal:  PLoS Med       Date:  2012-07-31       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.